Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonsystemic vasculitic neuropathy.

P J Dyck1, T J Benstead, D L Conn

  • 1Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905.

Brain : a Journal of Neurology
|August 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechano growth factor interacts with nucleolin to protect against cisplatin-induced neurotoxicity.

Experimental neurology·2020
Same author

Optimising seed processing techniques to improve germination and sowability of native grasses for ecological restoration.

Plant biology (Stuttgart, Germany)·2018
Same author

A complex case of Down syndrome in mother and fetus: obstetric and ethical considerations.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2012
Same author

Parental environment changes the dormancy state and karrikinolide response of Brassica tournefortii seeds.

Annals of botany·2012
Same author

Familial Alzheimer's disease and inherited prion disease in the UK are poorly ascertained.

Journal of neurology, neurosurgery, and psychiatry·2010
Same author

Long-term trends in carpal tunnel syndrome.

Neurology·2009
Same journal

Disrupted WWOX-MYC interplay impairs neurogenesis in human brain organoids.

Brain : a journal of neurology·2026
Same journal

SMPD4 deficiency disrupts indirect neurogenesis and neuronal migration in gyrencephalic cortex.

Brain : a journal of neurology·2026
Same journal

Retinal hyper-reflective foci link retinal and cortical pathology in paediatric multiple sclerosis.

Brain : a journal of neurology·2026
Same journal

Two scripts, two pathways: dorsal-ventral biases in post-stroke kana-kanji agraphia.

Brain : a journal of neurology·2026
Same journal

Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity.

Brain : a journal of neurology·2026
Same journal

Time to reconsider risk for psychosis?

Brain : a journal of neurology·2026
See all related articles

Nonsystemic vasculitic neuropathy affects only nerves, differing from systemic forms. While prednisone may help, outcomes vary, with some patients worsening or dying, highlighting the need for effective necrotizing vasculitis treatments.

Area of Science:

  • Neurology
  • Rheumatology
  • Pathology

Background:

  • Necrotizing vasculitis can manifest as systemic or nonsystemic vasculitic neuropathy.
  • Nonsystemic vasculitic neuropathy primarily affects peripheral nerves with minimal systemic symptoms.
  • Pathologically, it involves ischemic neuropathy due to small arteriole necrotizing vasculitis.

Purpose of the Study:

  • To characterize the clinical presentation and outcomes of patients with nonsystemic vasculitic neuropathy.
  • To compare the prognosis of nonsystemic vasculitic neuropathy with systemic necrotizing vasculitis.

Main Methods:

  • Retrospective analysis of 65 patients with necrotizing vasculitis.
  • Detailed review of clinical and pathological features in 20 patients with nonsystemic vasculitic neuropathy.

Related Experiment Videos

  • Outcome assessment including disease progression, patient status, and mortality.

    • Main Results:

    • Twenty patients had nonsystemic vasculitic neuropathy with symptoms for a median of 11.5 years.
    • Neuropathy patterns included multiple mononeuropathy (13), asymmetric (4), distal polyneuropathy (3), and sensory polyneuropathy (1).
    • Outcomes for nonsystemic vasculitic neuropathy: 8 worse, 5 better, 4 same, 3 deceased (unrelated causes). Prednisone showed potential benefit.
    • In contrast, 12 of 41 patients with systemic necrotizing vasculitis died within a median of 1.5 years.

    Conclusions:

    • Nonsystemic vasculitic neuropathy presents a distinct clinical entity with a chronic course.
    • While outcomes can vary, early intervention and management strategies are crucial.
    • Further research into effective treatments for necrotizing vasculitis is warranted.